Shopping Cart
- Remove All
- Your shopping cart is currently empty
Apstatin TFA is a potent inhibitor of aminopeptidase P (APP), with Ki values of 2.6 µM for rat APP and 0.64 µM for human APP. This compound also exhibits cardioprotective properties.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Apstatin TFA is a potent inhibitor of aminopeptidase P (APP), with Ki values of 2.6 µM for rat APP and 0.64 µM for human APP. This compound also exhibits cardioprotective properties. |
In vivo | Administered at 1 mg/kg intravenously, 5 minutes prior to induced ischemia, Apstatin TFA has been shown to reduce myocardial infarct size (IS) in models of acute myocardial ischemia [1]. |
Molecular Weight | 573.56 |
Formula | C25H34F3N5O7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.